Time‑order effects of vitamin C on hexavalent chromium‑induced mitochondrial damage and DNA‑protein crosslinks in cultured rat peripheral blood lymphocytes

Xiao,Fang; Chen,Dongfang; Luo,Lei; Zhong,Xiali; Xie,Ying; Zou,Lianhong; Zeng,Ming; Guan,Lan; Zhong,Caigao

doi:10.3892/mmr.2013.1462

Time‑order effects of vitamin C on hexavalent chromium‑induced mitochondrial damage and DNA‑protein crosslinks in cultured rat peripheral blood lymphocytes

Authors:
- Fang Xiao
- Dongfang Chen
- Lei Luo
- Xiali Zhong
- Ying Xie
- Lianhong Zou
- Ming Zeng
- Lan Guan
- Caigao Zhong
View Affiliations

Affiliations: Department of Health Toxicology, School of Public Health, Central South University, Changsha, Hunan 410078, P.R. China, Center for Disease Control and Prevention of Henan Province, Zhengzhou, Henan 450000, P.R. China, Department of Health Toxicology, School of Public Health, Central South University, Changsha, Hunan 410078, P.R. China
Published online on: May 8, 2013 https://doi.org/10.3892/mmr.2013.1462
Pages: 53-60

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hexavalent chromium [Cr(VI)] and its compounds have extensive applications in many industries and are widely known to cause occupational diseases as well as carcinogenic effects in humans. Mitochondrial damage, which is important in Cr(VI)‑induced cytotoxicity, may be characterized by the opening status of the permeability transition pore, the maintenance of the mitochondrial membrane potential and the level of malondialdehyde. The formation of DNA‑protein crosslinks (DPCs) in target tissues appears to be the direct and primary genotoxic effect of Cr(VI) exposure, and the lymphocytic DPCs may be viewed as a biomarker of internal Cr(VI) accumulation. It is well known that vitamin C (vit C) is an important biological reducing agent in humans and animals, which is capable of reducing Cr(VI). Regardless of the evidence from cell culture and in vivo experiments of the protective effect of the antioxidant, vit C, following exposure to Cr(VI), no studies have been conducted to date to demonstrate the time‑order effects of vit C on Cr(VI)‑induced mitochondrial damage and DPC formation. In the present study, by using peripheral blood lymphocytes from Sprague‑Dawley rats, we demonstrated that vit C pre‑ and co‑treatment have a protective effect against Cr(VI)‑induced loss of cell viability and mitochondrial damage, while only vit C co‑treatment has a protective effect against the Cr(VI)‑induced increase in DPCs. The mechanistic investigation revealed that cellular reactive oxygen species levels are correlated with Cr(VI)‑induced mitochondrial damage, and that p53 expression is correlated with the Cr(VI)‑induced increase in DPCs. We concluded that vit C exerts different time‑order effects on Cr(VI)‑induced mitochondrial damage and DPC formation, and that biomarkers, including DPC and p53, may be used in the assessment of the development of Cr(VI)‑induced cancer. These findings facilitate more detailed follow‑up of the Cr(VI)‑exposure populations for secondary prevention.

View Figures

View References

1	Nriagu JO and Nieboer E: Chromium in the Natural and Human Environments. 1st edition. Wiley; New York: 1988
2	Katz SA and Salem H: The Biological and Environmental Chemistry of Chromium. VCH Publishers; New York: 1994
3	Voitkun V, Zhitkovich A and Costa M: Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells. Nucleic Acids Res. 26:2024–2030. 1998. View Article : Google Scholar : PubMed/NCBI
4	Sathwara NG, Patel KG, Vyas JB, et al: Chromium exposure study in chemical based industry. J Environ Biol. 28:405–408. 2007.PubMed/NCBI
5	Chun L, Hongzhang C and Zuohu L: Adsorptive removal of Cr(VI) by Fe-modified steam exploded wheat straw. Process Biochem. 39:541–545. 2004. View Article : Google Scholar
6	McBride HM, Neuspiel M and Wasiak S: Mitochondria: more than just a powerhouse. Curr Biol. 16:R551–R560. 2006. View Article : Google Scholar : PubMed/NCBI
7	Hodges NJ, Adám B, Lee AJ, Cross HJ and Chipman JK: Induction of DNA-strand breaks in human peripheral blood lymphocytes and A549 lung cells by sodium dichromate: association with 8-oxo-2-deoxyguanosine formation and inter-individual variability. Mutagenesis. 16:467–474. 2001. View Article : Google Scholar
8	Costa M, Zhitkovich A and Toniolo P: DNA-protein cross-links in welders: molecular implications. Cancer Res. 53:460–463. 1993.PubMed/NCBI
9	Budhwar R, Das M, Bihari V and Kumar S: Exposure estimates of chromeplaters in India: an exploratory study. Biomarkers. 10:252–257. 2005. View Article : Google Scholar : PubMed/NCBI
10	Medeiros MG, Rodrigues AS, Batoréu MC, Laires A, Rueff J and Zhitkovich A: Elevated levels of DNA-protein crosslinks and micronuclei in peripheral lymphocytes of tannery workers exposed to trivalent chromium. Mutagenesis. 18:19–24. 2003. View Article : Google Scholar : PubMed/NCBI
11	Zhitkovich A, Lukanova A, Popov T, et al: DNA-protein crosslinks in peripheral lymphocytes of individuals exposed to hexavalent chromium compounds. Biomarkers. 1:86–93. 1996. View Article : Google Scholar : PubMed/NCBI
12	Quievryn G, Peterson E, Messer J and Zhitkovich A: Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells. Biochemistry. 42:1062–1070. 2003. View Article : Google Scholar : PubMed/NCBI
13	De Flora S and Wetterhahn KE: Mechanisms of chromium metabolism and genotoxicity. Life Chem Rep. 7:169–244. 1989.
14	Wei YD, Tepperman K, Huang M, Sartor MA and Puga A: Chromium inhibits transcription from polycyclic aromatic hydrocarbon-inducible promoters by blocking the release of histone deacetylase and preventing the binding of p300 to chromatin. J Biol Chem. 279:4110–4119. 2004. View Article : Google Scholar
15	Schnekenburger M, Talaska G and Puga A: Chromium cross-links histone deacetylase 1-DNA methyltransferase 1 complexes to chromatin, inhibiting histone-remodeling marks critical for transcriptional activation. Mol Cell Biol. 27:7089–7101. 2007. View Article : Google Scholar
16	Mattagajasingh SN and Misra HP: Mechanisms of the carcinogenic chromium(VI)-induced DNA-protein cross-linking and their characterization in cultured intact human cells. J Biol Chem. 271:33550–33560. 1996. View Article : Google Scholar : PubMed/NCBI
17	Ali SF, LeBel CP and Bondy SC: Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity. Neurotoxicology. 13:637–648. 1992.PubMed/NCBI
18	Valko M, Rhodes CJ, Moncol J, Izakovic M and Mazur M: Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 160:1–40. 2006. View Article : Google Scholar : PubMed/NCBI
19	Xu XR, Li HB, Gu JD and Li XY: Kinetics of the reduction of chromium(VI) by vitamin C. Environ Toxicol Chem. 24:1310–1314. 2005. View Article : Google Scholar : PubMed/NCBI
20	Chorvatovicová D, Ginter E, Kosinová A and Zloch Z: Effect of vitamins C and E on toxicity and mutagenicity of hexavalent chromium in rat and guinea pig. Mutat Res. 262:41–46. 1991.PubMed/NCBI
21	Stearns DM, Kennedy LJ, Courtney KD, Giangrande PH, Phieffer LS and Wetterhahn KE: Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro. Biochemistry. 34:910–919. 1995. View Article : Google Scholar : PubMed/NCBI
22	Szablewski L, Sobczyk-Kopcioł A, Oleszczak B, Mrozikiewicz-Rakowska B, Karnafel W and Grytner-Zięcina B: Expression of glucose transporters in peripheral blood cells in patients with type 2 diabetes mellitus depending on the mode of therapy. Diabetologia Doświadczalna i Kliniczna. 7:204–212. 2007.
23	Piątkiewicz P, Czech A, Tatoń J and Górski A: Investigations of cellular glucose transport and its regulation under the influence of insulin in human peripheral blood lymphocytes. Endokrynol Pol. 61:182–187. 2010.PubMed/NCBI
24	Cinatl J Jr, Cinatl J, Driever PH, et al: Sodium valproate inhibits in vivo growth of human neuroblastoma cells. Anticancer Drugs. 8:958–963. 1997. View Article : Google Scholar : PubMed/NCBI
25	Zhitkovich A and Costa M: A simple, sensitive assay to detect DNA-protein crosslinks in intact cells and in vivo. Carcinogenesis. 13:1485–1489. 1992. View Article : Google Scholar : PubMed/NCBI
26	Brustovetsky N, Brustovetsky T, Jemmerson R and Dubinsky JM: Calcium-induced cytochrome c release from CNS mitochondria is associated with the permeability transition and rupture of the outer membrane. J Neurochem. 80:207–218. 2002. View Article : Google Scholar : PubMed/NCBI
27	Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254. 1976. View Article : Google Scholar : PubMed/NCBI
28	Emaus RK, Grunwald R and Lemasters JJ: Rhodamine 123 as a probe of transmembrane potential in isolated rat-liver mitochondria: spectral and metabolic properties. Biochim Biophys Acta. 850:436–448. 1986. View Article : Google Scholar : PubMed/NCBI
29	Zhitkovich A, Voitkun V, Kluz T and Costa M: Utilization of DNA-protein cross-links as a biomarker of chromium exposure. Environ Health Perspect. 106(Suppl 4): 969–974. 1998. View Article : Google Scholar : PubMed/NCBI
30	Li CJ, Zhang QM, Li MZ, Zhang JY, Yu P and Yu DM: Attenuation of myocardial apoptosis by alpha-lipoic acid through suppression of mitochondrial oxidative stress to reduce diabetic cardiomyopathy. Chin Med J (Engl). 122:2580–2586. 2009.PubMed/NCBI
31	Shaham J, Bomstein Y, Gurvich R, Rashkovsky M and Kaufman Z: DNA-protein crosslinks and p53 protein expression in relation to occupational exposure to formaldehyde. Occup Environ Med. 60:403–409. 2003. View Article : Google Scholar : PubMed/NCBI
32	Jennette KW: The role of metals in carcinogenesis: biochemistry and metabolism. Environ Health Perspect. 40:233–252. 1981. View Article : Google Scholar : PubMed/NCBI
33	Connett PH and Wetterhahn KE: Metabolism of the carcinogen chromate by cellular constituents. Struct Bonding. 54:93–124. 1983. View Article : Google Scholar
34	Michaelson-Richie ED, Loeber RL, Codreanu SG, et al: DNA-protein cross-linking by 1,2,3,4-diepoxybutane. J Proteome Res. 9:4356–4357. 2010. View Article : Google Scholar : PubMed/NCBI
35	Barker S, Weinfeld M and Murray D: DNA-protein crosslinks: their induction, repair, and biological consequences. Mutat Res. 589:111–135. 2005. View Article : Google Scholar : PubMed/NCBI
36	Oleinick NL, Chiu SM, Ramakrishnan N and Xue LY: The formation, identification, and significance of DNA-protein cross-links in mammalian cells. Br J Cancer. (Suppl 8): 135–140. 1987.PubMed/NCBI
37	Taioli E, Zhitkovich A, Toniolo P and Costa M: Normal values of DNA-protein crosslinks in mononuclear cells of a population of healthy controls. Cancer J. 8:76–79. 1995.
38	Xu X, Muller JG, Ye Y and Burrows CJ: DNA-protein cross-links between guanine and lysine depend on the mechanism of oxidation for formation of C5 vs C8 guanosine adducts. J Am Chem Soc. 130:703–709. 2008. View Article : Google Scholar : PubMed/NCBI
39	Bjorklund CC and Davis WB: Stable DNA-protein cross-links are products of DNA charge transport in a nucleosome core particle. Biochemistry. 46:10745–10755. 2007. View Article : Google Scholar : PubMed/NCBI
40	Giorgi C, Romagnoli A, Pinton P and Rizzuto R: Ca²⁺ signaling, mitochondria and cell death. Curr Mol Med. 8:119–130. 2008.
41	Nisoli E, Clementi E, Moncada S and Carruba MO: Mitochondrial biogenesis as a cellular signaling framework. Biochem Pharmacol. 67:1–15. 2004. View Article : Google Scholar : PubMed/NCBI
42	Son YO, Hitron JA, Wang X, et al: Cr(VI) induces mitochondrial-mediated and caspase-dependent apoptosis through reactive oxygen species-mediated p53 activation in JB6 CI41 cells. Toxicol Appl Pharmacol. 245:226–235. 2010. View Article : Google Scholar
43	Szabó I and Zoratti M: The mitochondrial megachannel is the permeability transition pore. J Bioenerg Biomembr. 24:111–117. 1992.PubMed/NCBI
44	Gottlieb E, Armour SM, Harris MH and Thompson CB: Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Cell Death Differ. 10:709–717. 2003. View Article : Google Scholar : PubMed/NCBI
45	Tuma DJ, Thiele GM, Xu D, Klassen LW and Sorrell MF: Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration. Hepatology. 23:872–880. 1996. View Article : Google Scholar : PubMed/NCBI
46	Xiao F, Feng X, Zeng M, Guan L, Hu Q and Zhong C: Hexavalent chromium induces energy metabolism disturbance and p53-dependent cell cycle arrest via reactive oxygen species in L-02 hepatocytes. Mol Cell Biochem. 371:65–76. 2012. View Article : Google Scholar : PubMed/NCBI
47	Xiao F, Li Y, Dai L, et al: Hexavalent chromium targets mitochondrial respiratory chain complex I to induce reactive oxygen species-dependent caspase-3 activation in L-02 hepatocytes. Int J Mol Med. 30:629–635. 2012.
48	Hemminki K, Partanen R, Koskinen H, Smith S, Carney W and Brandt-Rauf PW: The molecular epidemiology of oncoproteins. Serum p53 protein in patients with asbestosis. Chest. 109(3 Suppl): 22S–26S. 1996. View Article : Google Scholar : PubMed/NCBI
49	Hanaoka T, Yamano Y, Katsuno N, Kagawa J and Ishizu S: Elevated serum levels of pantropic p53 proteins in chromium workers. Scand J Work Environ Health. 23:37–40. 1997. View Article : Google Scholar : PubMed/NCBI
50	Kortenkamp A, Curran B and O’Brien P: Defining conditions for the efficient in vitro cross-linking of proteins to DNA by chromium(III) compounds. Carcinogenesis. 13:307–308. 1992. View Article : Google Scholar : PubMed/NCBI
51	Macfie A, Hagan E and Zhitkovich A: Mechanism of DNA-protein cross-linking by chromium. Chem Res Toxicol. 23:341–347. 2010. View Article : Google Scholar : PubMed/NCBI
52	Voitkun V and Zhitkovich A: Analysis of DNA-protein crosslinking activity of malondialdehyde in vitro. Mutat Res. 424:97–106. 1999. View Article : Google Scholar : PubMed/NCBI
53	Singh J, Carlisle DL, Pritchard DE and Patierno SR: Chromium-induced genotoxicity and apoptosis: relationship to chromium carcinogenesis (review). Oncol Rep. 5:1307–1318. 1998.PubMed/NCBI
54	Bianchi V, Celotti L, Lanfranchi G, et al: Genetic effects of chromium compounds. Mutat Res. 117:279–300. 1983. View Article : Google Scholar
55	Merk O and Speit G: Significance of formaldehyde-induced DNA-protein crosslinks for mutagenesis. Environ Mol Mutagen. 32:260–268. 1998. View Article : Google Scholar : PubMed/NCBI